Development of generic low molecular weight heparins: A perspectiveFAREED, Jawed; LEONG, Wendy; HOPPENSTEADT, Debra A et al.Hematology/oncology clinics of North America. 2005, Vol 19, Num 1, pp v-vi, issn 0889-8588, 18 p.Article

Low molecular weight heparin in childrenALBISETTI, Manuela; ANDREW, Maureen.European journal of pediatrics. 2002, Vol 161, Num 2, pp 71-77, issn 0340-6199Article

Attention à l'administration itérative d'HBPM au voyageurLECOMPTE, Thomas.Archives des maladies du coeur et des vaisseaux. Pratique. 2005, Num 136, issn 1261-694X, p. 10Article

Low-Molecular Weight Molluscan Glycosaminoglycan from Bivalve Katelysia opima (Gmelin)VIJAYABASKAR, P; BALASUBRAMANIAN, T; SOMASUNDARAM, S. T et al.Methods and findings in experimental and clinical pharmacology. 2008, Vol 30, Num 3, pp 175-180, issn 0379-0355, 6 p.Article

Low-molecular-weight heparin in pediatric patientsSUTOR, Anton Heinz; CHAN, Anthony K. C; MASSICOTTE, Patricia et al.Seminars in thrombosis and hemostasis. 2004, Vol 30, pp 31-39, issn 0094-6176, 9 p., SUP1Conference Paper

Extending the role of antithrombotic agents: An example based on the low-molecular-weight heparin, tinzaparinHAINER, James W; SPROGEL, Per; LINDENSTROEM, Ewa et al.Seminars in thrombosis and hemostasis. 2004, Vol 30, pp 3-9, issn 0094-6176, 7 p., SUP1Conference Paper

The effect of taurolidine on experimental thrombus formationKAPTANOGLU, Levent; KUCUK, Hasan Fehmi; COLAK, Elif et al.European journal of pharmacology. 2008, Vol 578, Num 2-3, pp 238-241, issn 0014-2999, 4 p.Article

Differentiating Low-Molecular-Weight Heparins Based on Chemical, Biological, and Pharmacologic Properties : Implications for the Development of Generic Versions of Low-Molecular-Weight HeparinsJESKE, Walter P; WALENGA, Jeanine M; HOPPENSTEADT, Debra A et al.Seminars in thrombosis and hemostasis. 2008, Vol 34, Num 1, pp 74-85, issn 0094-6176, 12 p.Article

Les héparines de bas poids moléculaire = Low molecular weight heparinsHELLEY, D.La Lettre du pneumologue. 2001, Vol 4, Num 5, pp 191-194, issn 1292-5977Article

Use of thromboelastography to demonstrate persistent anticoagulation after stopping enoxaparinSIMONS, R; MALLETT, S. V.Anaesthesia. 2007, Vol 62, Num 11, pp 1175-1178, issn 0003-2409, 4 p.Article

The effect of low molecular weight heparin (enoxaparin) on enhanced coagulation induced by crystalloid haemodilutionLLEWELLYN, R. L; JAMES, M. F. M.Anaesthesia. 2010, Vol 65, Num 10, pp 1013-1016, issn 0003-2409, 4 p.Article

Preoperative low molecular weight heparin reduces heparin responsiveness during cardiac surgeryBAR-YOSEF, Shahar; COZART, Heidi B; PHILLIPS-BUTE, Barbara et al.Canadian journal of anaesthesia. 2007, Vol 54, Num 2, pp 107-113, issn 0832-610X, 7 p.Article

Existe-t-il des différences entre les héparines de bas poids moléculaire ?BONEU, Bernard; GUERRERO, Felipe.STV. Sang thrombose vaisseaux. 2006, Vol 18, pp 6-10, issn 0999-7385, 5 p., NSArticle

A rare case of HITTS following prophylactic LMWH therapy in a blunt trauma victimBARNES, Stephen L; BERNARD, Andrew C; KEARNEY, Paul A et al.Injury. 2005, Vol 36, Num 2, pp 347-351, issn 0020-1383, 5 p.Article

A simple capillary electrophoresis method for the rapid separation and determination of intact low molecular weight and unfractionated heparinsPATEL, Rahul P; NARKOWICZ, Christian; HUTCHINSON, Joseph P et al.Journal of pharmaceutical and biomedical analysis. 2008, Vol 46, Num 1, pp 30-35, issn 0731-7085, 6 p.Article

Timing of postpartum enoxaparin administration and severe postpartum hemorrhageFREEDMAN, Rachel A; BAUER, Kenneth A; NEUBERG, Donna S et al.Blood coagulation & fibrinolysis. 2008, Vol 19, Num 1, pp 55-59, issn 0957-5235, 5 p.Article

Differential effects of heparin and low molecular weight heparin on osteoblastogenesis and adipogenesis in vitroOSIP, Stephanie L; BUTCHER, Martin; YOUNG, Edward et al.Thrombosis and haemostasis. 2004, Vol 92, Num 4, pp 803-810, issn 0340-6245, 8 p.Article

Guidelines on the use and monitoring of heparinBAGLIN, T; BARROWCLIFFE, T. W; COHEN, A et al.British journal of haematology. 2006, Vol 133, Num 1, pp 19-34, issn 0007-1048, 16 p.Article

The potential for circular dichroism as an additional facile and sensitive method of monitoring low-molecular-weight heparins and heparinoidsRUDD, Timothy R; SKIDMORE, Mark A; GUIMOND, Scott E et al.Thrombosis and haemostasis. 2009, Vol 102, Num 5, pp 874-878, issn 0340-6245, 5 p.Conference Paper

Generic low-molecular-weight heparins: Some practical considerationsFAREED, Jawed; LEONG, Wendy L; HOPPENSTEADT, Debra A et al.Seminars in thrombosis and hemostasis. 2004, Vol 30, Num 6, pp 703-713, issn 0094-6176, 11 p.Conference Paper

Structural features of low-molecular-weight heparins affecting their affinity to antithrombinBISIO, Antonella; VECCHIETTI, Davide; CITTERIO, Laura et al.Thrombosis and haemostasis. 2009, Vol 102, Num 5, pp 865-873, issn 0340-6245, 9 p.Conference Paper

Low molecular weight heparin in pregnancy: current issuesGREER, Ian; HUNT, Beverley J.British journal of haematology. 2005, Vol 128, Num 5, pp 593-601, issn 0007-1048, 9 p.Article

Edoxaban administration following enoxaparin: A pharmacodynamic, pharmacokinetic, and tolerability assessment in human subjectsZAHIR, Hamim; MATSUSHIMA, Nobuko; HALIM, Abdel-Baset et al.Thrombosis and haemostasis. 2012, Vol 108, Num 1, pp 166-175, issn 0340-6245, 10 p.Article

Aplasia cutis congenita and low molecular weight heparinSHARIF, Saba; HAY, Charles R. M; CLAYTON-SMITH, Jill et al.BJOG (Oxford. Print). 2005, Vol 112, Num 2, pp 256-258, issn 1470-0328, 3 p.Article

Immediate type hypersensitivity after injection of nadroparin (Fraxiparin)BEKKENK, Morcel W; VAN ZUUREN, Esther J.Thrombosis and haemostasis. 2005, Vol 94, Num 3, pp 673-674, issn 0340-6245, 2 p.Article